Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3

Adenoviral expression of a urokinase receptor - Targeted protease inhibitor inhibits neointima formation in murine and human blood vessels

Cartilage invasion by rheumatoid synovial fibroblasts in vivo is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor: Abstract

Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor

Afbraak van kraakbeenmatrix door rheumatoïde synoviocyten wordt geremd door een membraan gebonden plasmine remmer via gentherapie

Degradation of a cartilage-like matrix by rheumatoid synovial fibroblasts is inhibited by gene transfer with a cell surface-targeted plasmin inhibitor: abstract

Binding of human urokinase-type plasminogen activator to its receptor: Residues involved in species specificity and binding

The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by α2-macroglobulin receptor associated protein

Mitogenic effects of urokinase plasminogen activator (u-PA) on melanoma cell lines (abstract)

Urokinase and tissue-type plasminogen activator stimulate human vascular smooth muscle cell migration

In vitro invasive behavior of melanoma cells transfected with urokinase plasminogen activator mutants

The role of plasminogen activators in vascular pericellular proteolysis

Urokinase mediated, plasmin degradation of bone-like matrix

Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha

Tissue-type plasminogen activator and its inhibitor in rat aorta: Effect of endotoxin

Role of plasminogen activators and their inhibitor PAI-1 in pericellular proteolysis of smooth muscle cells and endothelial cells

Neue Gesichtspunkte der Melanompathogenese: Eigenschaften metastasierender und nicht-metastasierender humaner Melanomzellen

Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis

Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines

Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo